Shanghai Aladdin Biochemical Technology Co.,Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 174.71 million compared to CNY 125.83 million a year ago. Revenue was CNY 177.34 million compared to CNY 130.24 million a year ago.

Net income was CNY 50.26 million compared to CNY 41.29 million a year ago. Basic earnings per share from continuing operations was CNY 0.2571 compared to CNY 0.2092 a year ago. Diluted earnings per share from continuing operations was CNY 0.25 compared to CNY 0.2092 a year ago.